The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Herpes simplex virus: global infection prevalence and incidence estimates, 2016
Open accessAbstract
OBJECTIVE: To generate global and regional estimates for the prevalence and incidence of herpes simplex virus (HSV) type 1 and type 2 infection for 2016. METHODS: To obtain data, we undertook a systematic review to identify studies up to August 2018. Adjustments were made to account for HSV test sensitivity and specificity. For each World Health Organization (WHO) region, we applied a constant incidence model to pooled prevalence by age and sex to estimate the prevalence and incidence of HSV types 1 and 2 infections. For HSV type 1, we apportioned infection by anatomical site using pooled estimates of the proportions that were oral and genital. FINDINGS: In 2016, an estimated 491.5 million people (95% uncertainty interval, UI: 430.4 million-610.6 million) were living with HSV type 2 infection, equivalent to 13.2% of the world's population aged 15-49 years. An estimated 3752.0 million people (95% UI: 3555.5 million-3854.6 million) had HSV type 1 infection at any site, equivalent to a global prevalence of 66.6% in 0-49-year-olds. Differing patterns were observed by age, sex and geographical region, with HSV type 2 prevalence being highest among women and in the WHO African Region. CONCLUSION: An estimated half a billion people had genital infection with HSV type 2 or type 1, and several billion had oral HSV type 1 infection. Millions of people may also be at higher risk of acquiring human immunodeficiency virus (HIV), particularly women in the WHO African Region who have the highest HSV type 2 prevalence and exposure to HIV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As shown in global models, recurrent genital ulcer disease (GUD) episodes affect nearly 188 million people annually, a figure that underscores both the chronic nature of infection and the cumulative psychosocial and economic toll on affected individuals [17].”
From Primary Genital HSV-2 Infection in a Resource-Limited Setting: Diagnostic Challenges and Clinical Implications (2025) · cites this paper as [17]
In the citing paper
“Recent modelling analyses have estimated that in 2020 alone, approximately 25.6 million new HSV-2 infections occurred among individuals aged 15-49 years, contributing to a global prevalence exceeding 519 million, or 13.3% of this age group.”
From Primary Genital HSV-2 Infection in a Resource-Limited Setting: Diagnostic Challenges and Clinical Implications (2025) · cites this paper as [17]
In the citing paper
“Recent modelling analyses have estimated that in 2020 alone, approximately 25.6 million new HSV-2 infections occurred among individuals aged 15-49 years, contributing to a global prevalence exceeding 519 million, or 13.3% of this age group.”
From Primary Genital HSV-2 Infection in a Resource-Limited Setting: Diagnostic Challenges and Clinical Implications (2025) · cites this paper as [17]
In the citing paper
“The burden is disproportionately higher among women and individuals in LMICs, where diagnostic and preventive services remain limited [17].”
From Primary Genital HSV-2 Infection in a Resource-Limited Setting: Diagnostic Challenges and Clinical Implications (2025) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Self-citationVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationChlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016
Rowley, J., Vander Hoorn, S., Korenromp, E., Low, N., Unemo, M., Abu-Raddad, L. J., Chico, R. M., Smolak, A., Newman, L., Gottlieb, S., et al. (2019) · Bulletin of the World Health Organization · doi:10.2471/blt.18.228486 · Cited by 1,665
Self-citationGenital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications
COREY, L., ADAMS, H. G., BROWN, Z. A., & HOLMES, K. K. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-6-958 · Cited by 931
The Acquisition of Herpes Simplex Virus during Pregnancy
Brown, Z. A., Selke, S., Zeh, J., Kopelman, J., Maslow, A., Ashley, R. L., Watts, D. H., Berry, S., Herd, M., & Corey, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370801 · Cited by 782
Looker, K. J., Magaret, A. S., May, M. T., Turner, K. M. E., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140765 · Cited by 644
Self-citationGupta, R., Warren, T., & Wald, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61908-4 · Cited by 599
Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
Looker, K. J., Magaret, A. S., Turner, K. M. E., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0114989 · Cited by 519
Self-citationA Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2
Langenberg, A. G. M., Corey, L., Ashley, R. L., Leong, W. P., & Straus, S. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411904 · Cited by 510
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
Looker, K. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.046128 · Cited by 493
Self-citation
Cited by
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Zheng, Q., & Wang, X. (2025) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 410
Pathogenesis and virulence of herpes simplex virus
Zhu, S., & Viejo-Borbolla, A. (2021) · Virulence · doi:10.1080/21505594.2021.1982373 · Cited by 376
Optimization of AAV vectors to target persistent viral reservoirs
Colón-Thillet, R., Jerome, K. R., & Stone, D. (2021) · Virology Journal · doi:10.1186/s12985-021-01555-7 · Cited by 50
Catumbela, C. S. G., Giridharan, V. V., Barichello, T., & Morales, R. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00369-7 · Cited by 37
Stevens, A., Kashyap, S., Crofut, E., Alvarez-Cabrera, A. L., Jih, J., Liu, Y.-T., & Zhou, Z. H. (2025) · Journal of Virology · doi:10.1128/jvi.00504-25 · Cited by 5
HSV ‐1 ICP0 dimer domain adopts a novel β‐barrel fold
(2024) · doi:10.1002/prot.26673 · Cited by 1
Maksud, R. O., Antuke, N. R. P. P., & Qurrohman, T. (2025) · Cureus · doi:10.7759/cureus.95820 · Cited by 1
Metadata
- Authors
- James, C., Harfouche, M., Welton, N. J., Turner, K. M., Abu-Raddad, L. J., Gottlieb, S. L., & Looker, K. J.
- Venue
- Bulletin of the World Health Organization
- Publisher
- WHO Press
- Published
- 2020-03-25
- Volume
- 98
- Issue
- 5
- Pages
- 315-329
- ISSN
- 0042-9686 (ISSN-L)
- OpenAlex
- W3022275668
- Cited by
- 791
- References
- 94
- FWCI
- 52.84
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.